Retatrutide 12mg
Retatrutide is a multi-functional peptide drug that acts as an agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted approach enhances satiety, increases energy expenditure, and improves glucose metabolism. The drug is designed as a treatment for obesity, type 2 diabetes, and potentially other related metabolic disorders. buy Retatrutide 12mg
Retatrutide 12 mg resolved steatosis in more than 90% of patients with obesity, MASLD
Key takeaways:
- Retatrutide at its highest dose resolved steatosis in more than 90% of patients with obesity and MASLD.
- Mean relative liver fat reduction was greater than 80% at 8 mg and 12 mg doses.
Product Summary
Retatrutide is a novel synthetic peptide designed as a multi-receptor agonist targeting key metabolic pathways. Engineered to activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, Retatrutide has shown promising preclinical results in studies of metabolic regulation, weight management, and glycemic control. buy Retatrutide 12mg
Key Details
Molecular Formula: C223H343F3N46O70
Molecular Weight: 4845.44 g/mol
CAS Number:2381089-83-2
Potential Research Applications
- Metabolic and Endocrine Regulation
- Retatrutide is widely used in research to evaluate its effects on metabolic regulation, including studies on insulin secretion, weight management, and energy homeostasis in preclinical models.
- Obesity and Diabetes Research
- As a multi-receptor agonist, Retatrutide is being investigated for its potential to improve glycemic control and reduce body weight, making it valuable for preclinical studies related to obesity and type 2 diabetes.
retatrutide 12mg, 12mg retatrutide reconstitution, reconstitute retatrutide 12mg, retatrutide 12mg reconstitution, 12mg retatrutide, 12mg retatrutide peptide.
Reviews
There are no reviews yet.